2nd International CDKL5 Research Symposium
Westfield Marriott Washington Dulles
The Lincoln Forum
June 24, 2014
8:00am - 5:00pm
*Peliminary AGENDA
8:00 – 9:00 am |
Registration Breakfast in the Fairfax Dining Room |
9:00 – 9:15 am |
Welcome David Frame, PharmD and Katheryn Elibri, DO International Foundation for CDKL5 Research, USA |
9:15 – 10:00 am |
Current Understanding of CDKL5 |
10:00 – 10:45 am |
Updates from the International CDKL5 Database: Improving our Understanding of the CDKL5 Phenotype Dr. Helen Leonard and Jenny Downs, PhD Telethon Kids Institute, Australia |
10:45 – 11:15 am |
Control of CDKL5 levels in depolarized neurons Charlotte Kilstrup-Nielsen, PhD University of Insubria, Italy |
11:15 - 11:30 am |
Break - coffee, tea, refreshments in the Rotunda |
11:30 - 12:30 pm |
CDKL5 Mouse Models: characterization and molecular pathways Judy Wang, PhD, University of Pennsylvania, USA Maurizio Giustetto, PhD, University of Torino, Italy |
12:30 - 1:30 pm |
Lunch in the Fairfax Dining Room |
1:30 - 2:15 pm |
Modeling CDKL5 Disorder with iPS cells Priscilla Negraes, PhD University of California San Diego, USA |
2:15 - 2:45 pm |
GluD1 is a common altered player in neuronal differentiation from both MECP2-mutated and CDKL5-mutated iPS cells Alessandra Renieri, MD University of Siena, Italy |
2:45 - 3:30 pm |
The Epigenetics of CDKL5 |
3:30 - 3:45 pm |
Break - coffee, tea, refreshments in the Rotunda |
3:45 - 4:00 pm |
CDKL5 Clinical research and opportunities for collaboration among other rare epilepsies and disorders Katheryn Elibri Frame, DO, IFCR |
4:00 - 4:45 pm |
CDKL5 Centers of Excellence: The multidisciplinary approach to CDKL5 care, and exploring opportunities for translational research Walter Kaufmann, MD, Boston Children's Hospital Tim Benke, MD, PhD, Children's Hospital Colorado |
4:45 - 5:00 pm |
CDKL5 Research: Where do we go from here? Closing Remarks David Frame, PharmD |